Login to Your Account

Financings Roundup

Heat Seeking $25M; Sets Range for Proposed IPO

By Jennifer Boggs
Managing Editor

Tuesday, July 9, 2013
Heat Biologics, a firm founded in 2008 to develop an off-the-shelf allogeneic immunotherapy technology based on heat-shock proteins, is taking its place in biotech's bustling initial public offering (IPO) queue.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription